Mapping Exoplanets

The varied surfaces and atmospheres of planets make them interesting places to live, explore, and study from afar. Unfortunately, the great distance to exoplanets makes it impossible to resolve their disk with current or near-term technology. It is still possible, however, to deduce spatial inhomogeneities in exoplanets provided that different regions are visible at different times---this can be due to rotation, orbital motion, and occultations by a star, planet, or moon. Astronomers have so far constructed maps of thermal emission and albedo for short period giant planets. These maps constrain atmospheric dynamics and cloud patterns in exotic atmospheres. In the future, exo-cartography could yield surface maps of terrestrial planets, hinting at the geophysical and geochemical processes that shape them.Comment: Updated chapter for Handbook of Exoplanets, eds. Deeg & Belmonte. 17 pages, including 6 figures and 4 pages of reference

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS-mutation and bone metastasis

Current guidelines lack comprehensive information on the metastatic site-specific role of KRAS mutation in lung adenocarcinoma (LADC). We investigated the effect of KRAS mutation on overall survival (OS) in this setting. In our retrospective study, 500 consecutive Caucasian metastatic LADC patients with known KRAS mutational status were analyzed after excluding 32 patients with EGFR mutations. KRAS mutation incidence was 28.6%. The most frequent metastatic sites were lung (45.6%), bone (26.2%), adrenal gland (17.4%), brain (16.8%), pleura (15.6%) and liver (11%). Patients with intrapulmonary metastasis had significantly increased KRAS mutation frequency compared to those with extrapulmonary metastases (35% vs 26.5%, p=0.0125). In contrast, pleural dissemination and liver involvement were associated with significantly decreased KRAS mutation incidence (vs all other metastatic sites; 17% (p<0.001) and 16% (p=0.02) vs 33%, respectively). Strikingly, we found a significant prognostic effect of KRAS status only in the bone metastatic subcohort (KRAS-wild-type vs KRAS-mutant; median OS 9.7v 3.7 months; HR, 0.49; 95% CI, 0.31 to 0.79; p =0.003). Our study suggests that KRAS mutation frequency in LADC patients shows a metastatic site dependent variation and, moreover, that the presence of KRAS mutation is associated with significantly worse outcome in bone metastatic cases.(VLID)469049

Augmented reality–assisted microsurgical resection of brain arteriovenous malformations: illustrative case

Background: Arteriovenous malformations (AVMs) of the brain are vessel conglomerates of feeding arteries and draining veins that carry a risk of spontaneous and intraoperative rupture. Augmented reality (AR)-assisted neuronavigation permits continuous, real-time, updated visualization of navigation information through a heads-up display, thereby potentially improving the safety of surgical resection of AVMs. Observations: The authors report a case of a 37-year-old female presenting with a 2-year history of recurrent falls due to intermittent right-sided weakness and increasing clumsiness in the right upper extremity. Magnetic resonance imaging, magnetic resonance angiography, and cerebral angiography of the brain revealed a left parietal Spetzler-Martin grade III AVM. After endovascular embolization of the AVM, microsurgical resection using an AR-assisted neuronavigation system was performed. Postoperative angiography confirmed complete obliteration of arteriovenous shunting. The postsurgical course was unremarkable, and the patient remains in excellent health. Lessons: Our case describes the operative setup and intraoperative employment of AR-assisted neuronavigation for AVM resection. Application of this technology may improve workflow and enhance patient safety

Achieving Generalizable Robustness of Deep Neural Networks by Stability Training

We study the recently introduced stability training as a general-purpose method to increase the robustness of deep neural networks against input perturbations. In particular, we explore its use as an alternative to data augmentation and validate its performance against a number of distortion types and transformations including adversarial examples. In our image classification experiments using ImageNet data stability training performs on a par or even outperforms data augmentation for specific transformations, while consistently offering improved robustness against a broader range of distortion strengths and types unseen during training, a considerably smaller hyperparameter dependence and less potentially negative side effects compared to data augmentation.Comment: 18 pages, 25 figures; Camera-ready versio

EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer

Most patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) experience clinical benefit from selective KRASG12C inhibition, whereas patients with colorectal cancer bearing the same mutation rarely respond. To investigate the cause of the limited efficacy of KRASG12C inhibitors in colorectal cancer, we examined the effects of AMG510 in KRAS G12C colorectal cancer cell lines. Unlike NSCLC cell lines, KRAS G12C colorectal cancer models have high basal receptor tyrosine kinase (RTK) activation and are responsive to growth factor stimulation. In colorectal cancer lines, KRASG12C inhibition induces higher phospho-ERK rebound than in NSCLC cells. Although upstream activation of several RTKs interferes with KRASG12C blockade, we identify EGFR signaling as the dominant mechanism of colorectal cancer resistance to KRASG12C inhibitors. The combinatorial targeting of EGFR and KRASG12C is highly effective in colorectal cancer cells and patient-derived organoids and xenografts, suggesting a novel therapeutic strategy to treat patients with KRAS G12C colorectal cancer. SIGNIFICANCE: The efficacy of KRASG12C inhibitors in NSCLC and colorectal cancer is lineage-specific. RTK dependency and signaling rebound kinetics are responsible for sensitivity or resistance to KRASG12C inhibition in colorectal cancer. EGFR and KRASG12C should be concomitantly inhibited to overcome resistance to KRASG12C blockade in colorectal tumors.See related commentary by Koleilat and Kwong, p. 1094.This article is highlighted in the In This Issue feature, p. 1079

Additional JWST/NIRSpec transits of the rocky M dwarf exoplanet GJ 1132 b reveal a featureless spectrum

Funding: S.P. acknowledges support from NASA under award No. 80GSFC24M0006. H.R.W was funded by UK Research and Innovation (UKRI) framework under the UK government’s Horizon Europe funding guarantee for an ERC Starter grant (grant No. EP/Y006313/1). S.E.M. is supported by NASA through the NASA Hubble Fellowship grant HST-HF2-51563 awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS5-26555. L.A. acknowledges funding from UKRI STFC Consolidated grant ST/V000454/1 and is supported by the Klarman Fellowship. J.K. acknowledges financial support from Imperial College London through an Imperial College Research Fellowship grant.As an archetypal M-dwarf rocky exoplanet, GJ 1132 b has a varied history of atmospheric measurements. At 1.13 R⊕, 1.66 M⊕, and 580 K, it orbits a bright, slowly rotating M dwarf in a 1.6 day period, making it a prime target for characterization. In this study, we combine two JWST NIRSpec/G395H transits previously reported by E. M. May et al. (2023) with two new NIRSpec/G395M transits to constrain the presence of an atmosphere. This marks the first time the G395H and G395M modes have been combined for a single target, and we report no difference in the quality of data between the two modes. For rocky M-dwarf studies, G395H may still be preferred if stacking transits to utilize the high-resolution flux-calibrated stellar spectra and assess evolving stellar heterogeneity. GJ 1132 b’s coadded transmission spectrum is best fit with a flat line. A thin steam atmosphere is also consistent with the data, but this interpretation is driven almost entirely by the first transit, which suggests an increase in cool spot coverage-fraction derived from the flux-calibrated stellar spectra. This demonstrates the importance of always considering stellar heterogeneity evolution in multivisit transits, and also the importance of a “leave-one-transit-out” approach in modeling efforts of coadded transits. We combine these results with MIRI/LRS emission data to show that together, transmission and emission are consistent with only the thinnest of atmospheres. Given GJ 1132 b’s age and distance from the star, a thin atmosphere is not likely stable. Therefore, the simplest explanation is that GJ 1132 b is indeed a bare rock.Peer reviewe

Arsenic speciation in soil using high performance liquid chromatography/inductively coupled plasma/mass spectrometry

A method has been developed to identify and quantify As(III), As(V), and organoarsenic compounds in soil samples from the Rocky Mountain Arsenal (RMA) by high performance liquid chromatography/inductively coupled plasma/mass spectrometry (HPLC/ICP/MS). The soils were extracted using tetrabutylammonium hydroxide (TBAH) and sonication. The percentages of As(III), As(V), and organoarsenic species extracted from soil samples were 30, 50, and 100 respectively. The arsenic species were not altered during the extraction process. They were separated by reversed-phase, ion-pairing, HPLC using a microbore Inertsil-ODS{trademark} column. The HPLC column effluent was introduced into an ICP/MS system using a direct injection nebulizer (DIN). Detection limits of less than 1 pg were readily obtained for each arsenic species. Internal standards are recommended to increase accuracy and precision. Soil samples spiked with arsenic oxide, sodium arsenate, dimethylarsinic acid (DMAA), and chlorovinyl arsenious acid (CVAA) were extracted, identified and quantified with the HPLC/ICP/MS system. The soil samples were analyzed in support of the analytical needs of a thermal desorption treatability study being conducted at the RMA

JWST/NIRCam Transmission Spectroscopy of the Nearby Sub-Earth GJ 341b

We present a JWST/NIRCam transmission spectrum from $3.9-5.0$ $\mu$m of the recently-validated sub-Earth GJ 341b ($\mathrm{R_P} = 0.92$ $\mathrm{R_{\oplus}}$, $\mathrm{T_{eq}} = 540$ K) orbiting a nearby bright M1 star ($\mathrm{d} = 10.4$ pc, $\mathrm{K_{mag}}=5.6$). We use three independent pipelines to reduce the data from the three JWST visits and perform several tests to check for the significance of an atmosphere. Overall, our analysis does not uncover evidence of an atmosphere. Our null hypothesis tests find that none of our pipelines' transmission spectra can rule out a flat line, although there is weak evidence for a Gaussian feature in two spectra from different pipelines (at 2.3 and $2.9\sigma$). However, the candidate features are seen at different wavelengths (4.3 $\mu$m vs 4.7 $\mu$m), and our retrieval analysis finds that different gas species can explain these features in the two reductions (CO$_2$ at $3.1\sigma$ compared to O$_3$ at $2.9\sigma$), suggesting that they are not real astrophysical signals. Our forward model analysis rules out a low mean molecular weight atmosphere ($< 350\times$ solar metallicity) to at least $3\sigma$, and disfavors CH$_4$-dominated atmospheres at $1-3\sigma$, depending on the reduction. Instead, the forward models find our transmission spectra are consistent with no atmosphere, a hazy atmosphere, or an atmosphere containing a species that does not have prominent molecular bands across the NIRCam/F444W bandpass, such as a water-dominated atmosphere. Our results demonstrate the unequivocal need for two or more transit observations analyzed with multiple reduction pipelines, alongside rigorous statistical tests, to determine the robustness of molecular detections for small exoplanet atmospheres.Comment: 25 pages, 18 figures, 6 tables. Accepted for publication in A